Inspire Medical Systems Stock Performance
| INSP Stock | USD 137.37 2.70 1.93% |
On a scale of 0 to 100, Inspire Medical holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 1.63, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Inspire Medical will likely underperform. Please check Inspire Medical's value at risk, as well as the relationship between the skewness and day median price , to make a quick decision on whether Inspire Medical's current trending patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Inspire Medical Systems are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Inspire Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 185.5 M | |
| Total Cashflows From Investing Activities | -113.1 M |
Inspire Medical Relative Risk vs. Return Landscape
If you would invest 8,005 in Inspire Medical Systems on September 12, 2025 and sell it today you would earn a total of 5,732 from holding Inspire Medical Systems or generate 71.61% return on investment over 90 days. Inspire Medical Systems is currently generating 0.9663% in daily expected returns and assumes 5.1907% risk (volatility on return distribution) over the 90 days horizon. In different words, 46% of stocks are less volatile than Inspire, and 81% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Inspire Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Inspire Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Inspire Medical Systems, and traders can use it to determine the average amount a Inspire Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1862
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INSP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Based on monthly moving average Inspire Medical is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Inspire Medical by adding it to a well-diversified portfolio.
Inspire Medical Fundamentals Growth
Inspire Stock prices reflect investors' perceptions of the future prospects and financial health of Inspire Medical, and Inspire Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Inspire Stock performance.
| Return On Equity | 0.0654 | ||||
| Return On Asset | 0.0286 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 3.78 B | ||||
| Shares Outstanding | 29.06 M | ||||
| Price To Earning | 15.29 X | ||||
| Price To Book | 6.11 X | ||||
| Price To Sales | 4.69 X | ||||
| Revenue | 802.8 M | ||||
| EBITDA | 65.03 M | ||||
| Cash And Equivalents | 196.32 M | ||||
| Cash Per Share | 7.10 X | ||||
| Total Debt | 31.79 M | ||||
| Debt To Equity | 0.14 % | ||||
| Book Value Per Share | 22.94 X | ||||
| Cash Flow From Operations | 130.25 M | ||||
| Earnings Per Share | 1.46 X | ||||
| Total Asset | 808.38 M | ||||
| Retained Earnings | (291.91 M) | ||||
| Current Asset | 167.55 M | ||||
| Current Liabilities | 64.84 M | ||||
About Inspire Medical Performance
Assessing Inspire Medical's fundamental ratios provides investors with valuable insights into Inspire Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Inspire Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea in the United States and internationally. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Inspire Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 485 people.Things to note about Inspire Medical Systems performance evaluation
Checking the ongoing alerts about Inspire Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Inspire Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Inspire Medical is way too risky over 90 days horizon | |
| Inspire Medical appears to be risky and price may revert if volatility continues | |
| Over 99.0% of the company shares are owned by institutional investors |
- Analyzing Inspire Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Inspire Medical's stock is overvalued or undervalued compared to its peers.
- Examining Inspire Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Inspire Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Inspire Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Inspire Medical's stock. These opinions can provide insight into Inspire Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Inspire Stock Analysis
When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.